| Solid form screening-a review J Aaltonen, M Allesų, S Mirza, V Koradia, KC Gordon, J Rantanen European Journal of Pharmaceutics and Biopharmaceutics 71 (1), 23-37, 2009 | 349 | 2009 |
| Pharmaceutical co-crystals–an opportunity for drug product enhancement I Miroshnyk, S Mirza, N Sandler Expert opinion on drug delivery 6 (4), 333-341, 2009 | 220 | 2009 |
| Microfluidics-assisted engineering of polymeric microcapsules with high encapsulation efficiency for protein drug delivery J Pessi, HA Santos, I Miroshnyk, DA Weitz, S Mirza International journal of pharmaceutics 472 (1-2), 82-87, 2014 | 110 | 2014 |
| Microfluidic assembly of multistage porous silicon–lipid vesicles for controlled drug release B Herranz-Blanco, LR Arriaga, E Mäkilä, A Correia, N Shrestha, S Mirza, ... Lab on a Chip 14 (6), 1083-1086, 2014 | 85 | 2014 |
| Physical solid-state properties and dissolution of sustained-release matrices of polyvinylacetate GAG Novoa, J Heinämäki, S Mirza, O Antikainen, AI Colarte, AS Paz, ... European Journal of Pharmaceutics and Biopharmaceutics 59 (2), 343-350, 2005 | 83 | 2005 |
| Nanodispersions of taxifolin: Impact of solid-state properties on dissolution behavior AN Shikov, ON Pozharitskaya, I Miroshnyk, S Mirza, IN Urakova, ... International Journal of Pharmaceutics 377 (1-2), 148-152, 2009 | 74 | 2009 |
| Diversity in itraconazole cocrystals with aliphatic dicarboxylic acids of varying chain length A Shevchenko, I Miroshnyk, LO Pietila, J Haarala, J Salmia, K Sinervo, ... Crystal growth & design 13 (11), 4877-4884, 2013 | 58 | 2013 |
| Co-crystals: an emerging approach for enhancing properties of pharmaceutical solids S Mirza, I Miroshnyk, J Heinämäki, J Yliruusi Dosis 24, 90-96, 2008 | 58 | 2008 |
| Study of interaction between PEG carrier and three relevant drug molecules: piroxicam, paclitaxel, and hematoporphyrin YC Li, S Rissanen, M Stepniewski, O Cramariuc, T Róg, S Mirza, ... The Journal of Physical Chemistry B 116 (24), 7334-7341, 2012 | 56 | 2012 |
| Crystal morphology engineering of pharmaceutical solids: tabletting performance enhancement S Mirza, I Miroshnyk, J Heinämäki, O Antikainen, J Rantanen, P Vuorela, ... AAPS PharmSciTech 10 (1), 113-119, 2009 | 56 | 2009 |
| Enhanced dissolution and oral bioavailability of piroxicam formulations: modulating effect of phospholipids S Mirza, I Miroshnyk, MJ Habib, JF Brausch, MD Hussain Pharmaceutics 2 (4), 339-350, 2010 | 55 | 2010 |
| Microfluidic templated mesoporous silicon–solid lipid microcomposites for sustained drug delivery D Liu, B Herranz-Blanco, E Mäkilä, LR Arriaga, S Mirza, DA Weitz, ... ACS applied materials & interfaces 5 (22), 12127-12134, 2013 | 49 | 2013 |
| Insight into the solubility and dissolution behavior of piroxicam anhydrate and monohydrate forms U Paaver, A Lust, S Mirza, J Rantanen, P Veski, J Heinämäki, ... International journal of pharmaceutics 431 (1-2), 111-119, 2012 | 49 | 2012 |
| Insight into thermally induced phase transformations of erythromycin A dihydrate I Miroshnyk, L Khriachtchev, S Mirza, J Rantanen, J Heinämäki, J Yliruusi Crystal growth & design 6 (2), 369-374, 2006 | 44 | 2006 |
| Solid‐state properties and relationship between anhydrate and monohydrate of baclofen S Mirza, I Miroshnyk, J Rantanen, J Aaltonen, P Harjula, E Kiljunen, ... Journal of pharmaceutical sciences 96 (9), 2399-2408, 2007 | 34 | 2007 |
| Influence of solvents on the variety of crystalline forms of erythromycin S Mirza, I Miroshnyk, J Heinämäki, L Christiansen, M Karjalainen, ... The AAPS Journal 5 (2), 39-47, 2003 | 34 | 2003 |
| Hydroxypropyl methylcellulose-controlled crystallization of erythromycin A dihydrate crystals with modified morphology S Mirza, I Miroshnyk, J Heinämäki, J Rantanen, O Antikainen, ... Crystal Growth and Design 8 (10), 3526-3531, 2008 | 25 | 2008 |
| Understanding processing-induced phase transformations in erythromycin–PEG 6000 solid dispersions S Mirza, J Heinämäki, I Miroshnyk, J Rantanen, L Christiansen, ... Journal of pharmaceutical sciences 95 (8), 1723-1732, 2006 | 23 | 2006 |
| Thermodynamic and structural aspects of hydrated and unhydrated phases of 4-hydroxybenzamide GL Perlovich, LK Hansen, TV Volkova, S Mirza, AN Manin, ... Crystal Growth and Design 7 (12), 2643-2648, 2007 | 19 | 2007 |
| Nonappa; Yliruusi, J. Diversity in Itraconazole Cocrystals with Aliphatic Dicarboxylic Acids of Varying Chain Length A Shevchenko, I Miroshnyk, LO Pietilä, J Haarala, J Salmia, K Sinervo, ... Cryst. Growth Des 13 (11), 4877-4884, 2013 | 18 | 2013 |
Alex BunkerUniversity of HelsinkiVahvistettu sähköpostiosoite verkkotunnuksessa helsinki.fi
